Abstract
Temafloxacin, a new difluoro quinolone, inhibited the majority ofEnterobacteriaceae at ⩽ 1µg/ml. It was 4–8-fold less active than ciprofloxacin and 2-fold less active than ofloxacin. Cefotaxime and imipenem-resistant isolates such asEnterobacter cloacae, Citrobacter freundii, Pseudomonas aeruginosa, andAcinetobacter spp. were inhibited. Temafloxacin inhibitedNeisseria, Branhamella, andHaemophilus species at < 0.25µg/ml. Methicillin-susceptible and methicillin-resistantStaphylococcus aureus, Staphylococcus epidermidis andClostridium spp. were inhibited at concentrations less or equal to that of ciprofloxacin and ofloxacin.
Similar content being viewed by others
References
Wolfson, J. S., Hooper, D. C. The fluoroquinolones: structures, mechanisms of action and resistance and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy 1985, 28: 581–586.
Hirschhorn, L., Neu, H. C. Factors influencing the in vitro activity of two new aryl-fluoroquinolone anti-microbial agents, Difloxacin (A-56619) and A-56620. Antimicrobial Agents and Chemotherapy 1986, 30: 143–146.
Hardy, D. J., Swanson, R. N., Hensey, D. M., Ramer, N. R., Bower, R. R., Hanson, C. W., Chu, D. T. W., Fernandes, P. B. Comparative antibacterial activity of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones. Antimicrobial Agents and Chemotherapy 1987, 31: 1768–1774.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chin, N.X., Figueredo, V.M., Novelli, A. et al. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent. Eur. J. Clin. Microbiol. Infect. Dis. 7, 58–63 (1988). https://doi.org/10.1007/BF01962176
Issue Date:
DOI: https://doi.org/10.1007/BF01962176